Cromos Pharma, where the patients are

R&D Trends

Report: global pharma growth linked to expansion in emerging markets, best practices

Wednesday, February 12, 2014 01:46 PM

China is expected to generate 27% of the world's pharmaceutical growth from 2011 to 2015. The world's largest country by population, China also is the key to the economic engine of the emerging markets, according to a study from Best Practices, a research, consulting and publishing firm.

More... »

CRF Health eCOA webinar series

Debiopharm Group to acquire Affinium's Antibiotic clinical assets and platform

Wednesday, February 12, 2014 01:41 PM

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs for unmet medical and companion diagnostics, will acquire Affinium Pharmaceuticals’ clinical and preclinical assets, as well as its technology platform.

More... »


Medical Research Council awards $52.9 million to improve data research

Wednesday, February 12, 2014 01:34 PM

The Medical Research Council (MRC) has made an investment of $52.9 million to improve capability, capacity and capital infrastructure in medical bioinformatics.

More... »

Critical Path Institute receives grant for tuberculosis treatments

Wednesday, February 12, 2014 01:31 PM

The Critical Path Institute, an independent nonprofit that catalyzes innovative ideas to accelerate the speed of drug and medical product development, has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop quantitative mathematical models to optimize the design of clinical trials and tackle challenges facing the development of effective tuberculosis (TB) treatments.  

More... »

DaVita Clinical Research, Pyxant Labs to collaborate

Wednesday, February 12, 2014 01:23 PM

Pyxant Labs has partnered with DaVita Clinical Research (DCR), a specialty CRO with services for both drug and device development, to provide bioanalytical laboratory services for DCR's early clinical trials.

More... »

University of Edinburgh, Selcia to develop sleeping sickness treatment

Wednesday, February 12, 2014 01:18 PM

Scientists from the University of Edinburgh, working with international life sciences CRO Selcia, are launching a $4.1 million project to design novel treatments for sleeping sickness, which is spread by the bite of the tsetse fly and is prevalent in west and central Africa. It can damage the nervous system and cause coma, organ failure and death.

More... »

Innate Pharma acquires ANTI-NKG2A from Novo Nordisk

Monday, February 10, 2014 10:19 AM

Innate Pharma has acquired full development and commercialization rights to the anti-NKG2A antibody, a first-in-class immune checkpoint inhibitor ready for phase II development in oncology from global healthcare company Novo Nordisk.

More... »

Report: Absence of 2014 blockbuster drug launches puts R&D productivity at risk

Monday, February 10, 2014 09:54 AM

The past two years have brought a surge of R&D productivity, driving investor confidence and increasing market performance, but 2014 looks to tell a different tale according to a new report from EP Vantage, a source of life science market intelligence and analysis.

More... »

Seven California institutions awarded $40M to create Center of Excellence in Stem Cell Genomics

Thursday, February 6, 2014 11:43 AM

A team bringing together experts and investigators from seven different major California institutions has been awarded $40 million to create a new Center of Excellence in Stem Cell Genomics, by California's stem cell agency, the California Institute for Regenerative Medicine.

More... »

Merck forms collaborations with Amgen, Incyte, Pfizer

Thursday, February 6, 2014 11:41 AM

Merck has signed three separate clinical collaboration agreements, through subsidiaries, with Amgen, Incyte and Pfizer to evaluate novel combination regimens with MK-3475, Merck’s investigational anti-PD-1 immunotherapy. Financial terms have not been disclosed.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs